Security
National Health Investors · NHI
NHINYSECommon stockCurrentCIK 877860Updated Nov 1, 2026
NHI price & chart
Loading TradingView…
NYSE:NHI on TradingView ↗About the company
National Health Investors, Inc. (NYSE: NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust (“REIT”). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company’s real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. For more information, visit www.nhireit.com.
In the news
NHI Announces $107.7 Million SHOP Investment ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
144 filing
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
SCHEDULE 13G/A - filed by BlackRock, Inc. regarding NATIONAL HEALTH INVESTORS INC
Termination of a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets
Items 1.02, 2.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,690,064,000Source | 2,460,090,000Source | 2,964,202,000Source | 2,695,959,000Source | 2,476,912,000Source | 2,889,865,000Source | 2,782,885,000Source | 2,478,125,000Source | 2,796,887,000Source | 2,614,371,000Source | 2,488,480,000Source | 2,507,424,000Source |
| Property, Plant and Equipment, NetUSD | 2,302,668,000Source | 2,096,824,000Source | 2,566,472,000Source | 2,316,452,000Source | 2,106,324,000Source | 2,555,288,000Source | 2,270,257,000Source | 2,092,580,000Source | 2,473,758,000Source | 2,211,253,000Source | 2,107,082,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 81,625,000Source | 15,550,000Source | 30,388,000Source | 18,640,000Source | 14,766,000Source | 24,948,000Source | 135,004,000Source | 11,357,000Source | 19,624,000Source | 24,289,000Source | 22,347,000Source | 19,291,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 3,621,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | 4,540,000Source | — | — | — | — | — | 1,500,000Source | 1,524,000Source | 1,562,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,191,566,000Source | 1,212,682,000Source | 1,374,945,000Source | 1,198,665,000Source | 1,213,440,000Source | 1,357,331,000Source | 1,338,300,000Source | 1,210,559,000Source | 1,256,983,000Source | 1,229,194,000Source | 1,214,433,000Source | 1,217,518,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 476,000Source | 436,000Source | 491,000Source | 475,000Source | 434,000Source | 485,000Source | 467,000Source | 434,000Source | 483,000Source | 457,000Source | 434,000Source | 434,000Source |
| Retained Earnings (Accumulated Deficit)USD | 2,708,843,000Source | 2,561,587,000Source | 2,842,779,000Source | 2,675,981,000Source | 2,533,047,000Source | 2,787,108,000Source | 2,638,994,000Source | 2,497,791,000Source | 2,747,006,000Source | 2,604,829,000Source | 2,466,844,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 1,480,899,000Source | 1,228,950,000Source | 1,571,426,000Source | 1,479,645,000Source | 1,244,417,000Source | 1,514,775,000Source | 1,426,474,000Source | 1,247,972,000Source | 1,521,543,000Source | 1,366,475,000Source | 1,253,952,000Source | 1,270,225,000Source |
| Additional Paid in Capital, Common StockUSD | 1,875,800,000Source | 1,601,450,000Source | 1,966,642,000Source | 1,863,582,000Source | 1,606,199,000Source | 1,920,451,000Source | 1,804,679,000Source | 1,605,912,000Source | 1,922,713,000Source | 1,736,831,000Source | 1,603,757,000Source | 1,599,427,000Source |
| Liabilities and EquityUSD | 2,690,064,000Source | 2,460,090,000Source | 2,964,202,000Source | 2,695,959,000Source | 2,476,912,000Source | 2,889,865,000Source | 2,782,885,000Source | 2,478,125,000Source | 2,796,887,000Source | 2,614,371,000Source | 2,488,480,000Source | 2,507,424,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 8,565,000Source | 9,533,000Source | 7,464,000Source | 8,328,000Source | 9,886,000Source | 7,837,000Source | 8,571,000Source | 10,169,000Source | 8,166,000Source | 8,912,000Source | 10,439,000Source | 9,856,000Source |
| Additional Financial Items | ||||||||||||
| Dividends PayableUSD | 43,827,000Source | 39,260,000Source | 45,245,000Source | 42,726,000Source | 39,098,000Source | 44,610,000Source | 42,024,000Source | 39,082,000Source | 44,439,000Source | 41,119,000Source | 39,069,000Source | 39,050,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 9,034,000Source | 8,925,000Source | 10,367,000Source | 9,321,000Source | 9,169,000Source | 9,922,000Source | 9,540,000Source | 9,425,000Source | 10,195,000Source | 9,790,000Source | 9,656,000Source | 9,825,000Source |
| Deferred Income Tax Liabilities, Net | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 32,478,000Source | 28,242,000Source | 55,357,000Source | 36,689,000Source | 39,752,000Source | 33,817,000Source | 140,787,000Source | 136,639,000Source | 134,381,000Source | 65,501,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 53,440,000Source | 46,478,000Source | 236,563,000Source | 207,768,000Source | 184,450,000Source | 185,340,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -103,886,000Source | -75,469,000Source | -269,149,000Source | -192,315,000Source | -11,630,000Source | 197,945,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 294,034,000Source | 157,931,000Source | 49,556,000Source | 10,993,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 4,502,000Source | 128,000Source | 456,000Source | 5,819,000Source | 0Source | 288,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 151,951,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 55,770,000Source | 139,766,000Source | 25,708,000Source | -13,568,000Source | -169,719,000Source | -401,254,000Source |
| Dividends paid | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 0Source | 112,000Source | 200,815,000Source | 75,436,000Source | 415,427,000Source | 135,388,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 5,324,000Source | 110,775,000Source | -6,878,000Source | 1,885,000Source | 3,101,000Source | -17,969,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 81,625,000Source | 17,767,000Source | 50,434,000Source | 19,323,000Source | 24,948,000Source | 137,277,000Source | 19,624,000Source | 26,502,000Source | 24,617,000Source | 21,516,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 17,525,000Source | 16,873,000Source | 51,497,000Source | 55,374,000Source | 51,897,000Source | 42,659,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 983,000Source | 670,000Source | 2,360,000Source | 1,071,000Source | 2,240,000Source | 2,558,000Source | 5,576,000Source | 4,182,000Source | 4,605,000Source | 8,613,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 854,000Source | 978,000Source | 3,427,000Source | 6,583,000Source | 4,685,000Source | 4,283,000Source |
| DepreciationUSD | — | — | 20,216,000Source | 17,768,000Source | — | 19,918,000Source | — | 19,157,000Source | — | 71,443,000Source | 69,973,000Source | 70,880,000Source |
| Dividends PayableUSD | — | — | 43,827,000Source | 39,260,000Source | 45,245,000Source | 42,726,000Source | 44,610,000Source | 42,024,000Source | 44,439,000Source | 41,119,000Source | 39,069,000Source | 39,050,000Source |
| FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversalUSD | — | — | — | — | — | — | -56,000Source | 61,000Source | 3,452,000Source | 4,773,000Source | 138,000Source | — |
| Gain (Loss) on Sale of DerivativesUSD | — | — | — | — | — | — | — | — | 0Source | 6,261,000Source | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | — | — | — | — | — | — | -6,261,000Source | — | — |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | 20,000Source | -710,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | -73,000Source | -151,000Source |
| Gains (Losses) on Sales of Investment Real EstateUSD | — | — | 113,000Source | 102,000Source | 21,967,000Source | 110,000Source | 2,612,000Source | 114,000Source | 456,000Source | 6,678,000Source | 14,721,000Source | 28,342,000Source |
| General and Administrative ExpenseUSD | — | — | 6,311,000Source | 4,810,000Source | 8,823,000Source | 6,125,000Source | 7,851,000Source | 6,829,000Source | 26,868,000Source | 20,736,000Source | 19,314,000Source | 22,768,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 73,000Source | 0Source | 0Source | 1,524,000Source | 0Source | 415,000Source | 3,664,000Source | 402,000Source | 555,000Source | 569,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 32,862,000Source | 28,540,000Source | 55,671,000Source | 36,987,000Source | 40,102,000Source | 34,165,000Source | 142,177,000Source | 137,985,000Source | 135,654,000Source | 66,403,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -384,000Source | -298,000Source | -314,000Source | -298,000Source | -350,000Source | -348,000Source | -1,390,000Source | -1,346,000Source | -1,273,000Source | -902,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 32,812,000Source | 28,511,000Source | 55,576,000Source | 36,938,000Source | 40,024,000Source | 34,113,000Source | 141,976,000Source | 137,867,000Source | 135,597,000Source | — |
| Operating ExpensesUSD | — | — | 57,555,000Source | 54,804,000Source | 87,283,000Source | 55,607,000Source | 78,025,000Source | 56,008,000Source | 238,961,000Source | 211,883,000Source | 200,879,000Source | 241,856,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 65,483,000Source | 181,533,000Source | 142,394,000Source | 0Source | 0Source |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | 1,746,000Source | 1,170,000Source | 2,973,000Source | 11,738,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | — | — | — | — | — | — | — | — | — | 10,628,000Source |
| Income Tax Expense (Benefit) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 89,847,000Source | 82,944,000Source | 121,319,000Source | 90,662,000Source | 115,130,000Source | 89,296,000Source | 375,628,000Source | 335,181,000Source | 319,835,000Source | 278,194,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -384,000Source | -298,000Source | -314,000Source | -298,000Source | -350,000Source | -348,000Source | -1,390,000Source | -1,346,000Source | -1,273,000Source | -902,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 32,862,000Source | 28,540,000Source | 55,671,000Source | 36,987,000Source | 40,102,000Source | 34,165,000Source | 142,177,000Source | 137,985,000Source | 135,654,000Source | 66,403,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.69Source | 0.66Source | 1.15Source | 0.79Source | 0.83Source | 0.75Source | 3.03Source | 3.14Source | 3.13Source | 1.48Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.69Source | 0.65Source | 1.15Source | 0.79Source | 0.82Source | 0.74Source | 3.02Source | 3.13Source | 3.13Source | 1.48Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 47,433,336Source | 43,476,067Source | 48,435,914Source | 46,691,953Source | 48,323,945Source | 45,720,496Source | 46,874,691Source | 43,844,771Source | 43,388,794Source | 44,774,708Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 47,623,623Source | 43,987,072Source | 48,498,181Source | 46,822,465Source | 48,547,893Source | 45,878,528Source | 47,051,763Source | 44,102,636Source | 43,389,466Source | 44,794,236Source |
| Additional Financial Items | ||||||||||||
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.92Source | 0.9Source | 0.92Source | 0.9Source | 0.92Source | 0.9Source | 3.64Source | 3.6Source | 3.6Source | 3.6Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | 25,548,000Source | 19,918,000Source | 23,691,000Source | 19,157,000Source | 80,944,000Source | — | — | — |
| FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversalUSD | — | — | — | — | — | — | -56,000Source | 61,000Source | 3,452,000Source | 4,773,000Source | 138,000Source | — |
| Gains (Losses) on Sales of Investment Real EstateUSD | — | — | 113,000Source | 102,000Source | 21,967,000Source | 110,000Source | 2,612,000Source | 114,000Source | 456,000Source | 6,678,000Source | 14,721,000Source | 28,342,000Source |
| General and Administrative ExpenseUSD | — | — | 6,311,000Source | 4,810,000Source | 8,823,000Source | 6,125,000Source | 7,851,000Source | 6,829,000Source | 26,868,000Source | 20,736,000Source | 19,314,000Source | 22,768,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 73,000Source | 0Source | 0Source | 1,524,000Source | 0Source | 415,000Source | 3,664,000Source | 402,000Source | 555,000Source | 569,000Source |
| Interest ExpenseUSD | — | — | 13,766,000Source | 14,939,000Source | 15,814,000Source | 15,001,000Source | 15,040,000Source | 14,337,000Source | 57,368,000Source | 59,903,000Source | 58,160,000Source | 44,917,000Source |
| InterestExpenseOperatingUSD | — | — | 13,766,000Source | 14,939,000Source | 15,814,000Source | 15,001,000Source | 15,040,000Source | 14,337,000Source | 57,368,000Source | 59,903,000Source | — | — |
| Interest Income (Expense), NetUSD | — | — | — | 69,414,000Source | — | — | — | — | — | — | 268,735,000Source | 240,213,000Source |
| Interest Income, OperatingUSD | — | — | — | — | — | — | — | — | — | — | — | 24,698,000Source |
| Labor and Related ExpenseUSD | — | — | 7,168,000Source | 4,304,000Source | 18,297,000Source | 4,324,000Source | 14,699,000Source | 4,299,000Source | 27,532,000Source | 17,166,000Source | — | — |
| Lease IncomeUSD | — | — | 62,178,000Source | 63,318,000Source | 71,390,000Source | 70,270,000Source | 73,150,000Source | 68,866,000Source | 271,600,000Source | 257,049,000Source | 249,227,000Source | 217,700,000Source |
| Management Fee ExpenseUSD | — | — | — | — | 2,172,000Source | 710,000Source | 1,946,000Source | 691,000Source | 3,997,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 32,812,000Source | 28,511,000Source | 55,576,000Source | 36,938,000Source | 40,024,000Source | 34,113,000Source | 141,976,000Source | 137,867,000Source | 135,597,000Source | — |
| Operating ExpensesUSD | — | — | 57,555,000Source | 54,804,000Source | 87,283,000Source | 55,607,000Source | 78,025,000Source | 56,008,000Source | 238,961,000Source | 211,883,000Source | 200,879,000Source | 241,856,000Source |
| Other Operating IncomeUSD | — | — | — | — | — | — | — | — | — | — | 202,000Source | — |
| Income Tax Expense (Benefit) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Interest Expense (non-operating) | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
ex991-q22026earningsrelease.htm · 8-K · 2026-08-10
EX-99.1 2 ex991-q22026earningsrelease.htm EX-99.1 Document Exhibit 99.1 Contact: Todd M. Siefert, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2026 Results MURFREESBORO, Tenn. - (Monday, August 10, 2026) National Health Investors, Inc. (NYSE: NHI) announced today its results for the quarter ended June 30, 2026. CEO Comments “We continued to expand our Senior Housing Operating Portfolio (“SHOP”) with second quarter invested capital of $854.8 million, a 137…
Read attachment ↗ex991-q12026earningsrelease.htm · 8-K · 2026-05-04
EX-99.1 2 ex991-q12026earningsrelease.htm EX-99.1 Document Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2026 Results MURFREESBORO, Tenn. - (Monday, May 4, 2026) National Health Investors, Inc. (NYSE: NHI) announced today its results for the quarter ended March 31, 2026. CEO Comments “NHI reported a solid start to 2026, with NAREIT FFO, Normalized FFO and FAD exceeding our internal expectations,” said Eric Mendelsohn, NH…
Read attachment ↗d124690dex991.htm · 8-K · 2026-04-23
EX-99.1 3 d124690dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Dana Hambly, Senior Vice President, Finance Phone: (615) 890-9100 NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor MURFREESBORO, Tenn. - (April 23, 2026) - National Health Investors, Inc. (NYSE: NHI) announced today that John Spaid, Executive Vice President and Chief Financial Officer, will retire effective July 1, 2026. To support a seamless transition, the Company will appoint Todd S…
Read attachment ↗d114456dex991.htm · 8-K · 2026-03-16
EX-99.1 4 d114456dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 FORM OF REGISTERED FORWARD CONFIRMATION Date: [•], 20[•] To: National Health Investors, Inc. ──────────────────────────────────────────── 222 Robert Rose Drive Murfreesboro, Tennessee 37129 From: [DEALER NAME AND NOTICE INFORMATION] ─────────────────────────────────────────────────── Re: Registered Forward Transaction ─────────────────────────────────────────── Ladies and Gentlemen: The purpose of this…
Read attachment ↗ex991-q42025earningsrelease.htm · 8-K · 2026-02-26
EX-99.1 2 ex991-q42025earningsrelease.htm EX-99.1 Document Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Fourth Quarter 2025 Results MURFREESBORO, Tenn. - (Thursday, February 26, 2026) National Health Investors, Inc. (NYSE: NHI) announced today its results for the fourth quarter and year ended December 31, 2025. CEO Comments “NHI generated strong financial results in 2025 that exceeded our initial NAREIT FFO, Normalized FFO and FAD gu…
Read attachment ↗ex48-descriptionofsecuriti.htm · 10-K · 2026-02-26
Exhibit 4.8 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the capital stock of National Health Investors, Inc. (the “Company,” “us,” “our” or “we”) is a summary of the rights of our common stock and certain provisions of Maryland General Corporation Law and our articles of incorporation, as amended (our “articles”) and amended and restated bylaws (our “bylaws”), as currently in effect. This description is a summa…
Read attachment ↗